Track market-moving stories before they get noisy

New class action for Hub Group (HUBG) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 8/28/2026

Cabot (CBT - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.

Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.

Therefore, the Zacks rating upgrade for Cabot basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.

For Cabot, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.

Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for CabotThis chemical company is expected to earn $6.35 per share for the fiscal year ending September 2026, which represents no year-over-year change.

Analysts have been steadily raising their estimates for Cabot. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.3%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of Cabot to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.

Healthcare Added 35,200 Jobs—3 Stocks Positioned to BenefitHCA Healthcare NYSE: HCA said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population.

Chief Executive Officer Sam Hazen said the expiration of enhanced premium tax credits at the end of 2025 led more patients to lose exchange coverage than the company had anticipated. While HCA expected some individuals to move to other coverage options, Hazen said patients instead migrated “almost one for one” to uninsured status while continuing to require hospital care.

Get HCA Healthcare alerts:

The Aging of America Could Make HCA Healthcare a Long-Term Winner“The effects, as expected, were that many people became uninsured and still needed emergency care from hospitals,” Hazen said. He added that the impact in the first half of 2026 was greater than the company’s original estimates.

Payer Mix Shift Drives Updated Outlook Same-facility equivalent admissions among patients covered through health insurance exchanges declined 15% in the second quarter and year to date, according to Chief Financial Officer Mike Marks. Equivalent admissions among insured patients excluding exchange plans increased 3.2% in the second quarter, while total uninsured equivalent admissions rose 15%.

This ETF Is Proof That the Healthcare Rebound Is RealMarks said the exchange-related payer mix shift created an approximately $400 million unfavorable impact on adjusted EBITDA in the second quarter. That figure included about $75 million tied to a higher estimate of the first-quarter exchange impact.

The company now expects the full-year adjusted EBITDA impact from health insurance exchange changes to range from negative $1 billion to negative $1.2 billion. Marks said the updated outlook reflects the company’s conclusion that nearly all patients losing exchange coverage are becoming uninsured, compared with its prior assumption that 80% to 85% would do so. HCA also said its original expectation that uninsured patients would use fewer healthcare services did not materialize.

Three divisions—Gulf Coast, North Florida and South Atlantic—accounted for about half of the companywide exchange-related impact. Hazen said exchange adjusted admissions in those divisions declined between 25% and 28% in the first half.

HCA revised its full-year 2026 guidance to:

Revenue of $77 billion to $79.5 billion. Adjusted EBITDA of $15.4 billion to $16.1 billion. Net income attributable to HCA Healthcare of $6.3 billion to $6.7 billion. Diluted earnings per share of $28.70 to $30.50. Marks said the revised outlook is more consistent with HCA’s long-term adjusted EBITDA growth target of 4% to 6%, following moderation from the company’s 2025 growth rate and its initial 2026 assumptions.

Medicaid Programs Offset Pressure in the Quarter The company recognized approximately $400 million of incremental net benefit from Medicaid supplemental payment programs during the second quarter. That included a $540 million incremental net benefit related to a recently approved Florida program covering the period from Oct. 1, 2024, through June 30, 2026, or 21 months.

The Florida benefit was partly offset by retroactive payments received in the second quarter of 2025. HCA’s annual guidance assumes a net Medicaid supplemental-payment benefit of $300 million to $500 million, but Marks said the outlook implies a $100 million to $300 million headwind in the second half because prior program approvals and retroactive payments are expected to exceed the incremental benefit from the Florida program.

Hazen described Medicaid supplemental programs as important to supporting access to care for Medicaid patients, particularly as hospitals provide more uncompensated care to uninsured patients.

Demand Growth Continues, Though Surgeries Decline Same-facility admissions increased 2.5% in the second quarter, while equivalent admissions rose 2.7%. Emergency room visits increased 3.6%, with cardiac procedures and rehabilitation volumes also contributing to demand.

However, inpatient surgeries declined 2.3% and outpatient surgeries fell 3.4%. Hazen attributed much of the decline to reduced demand for elective procedures, including patients previously covered through exchange plans. He also cited physician feedback regarding affordability pressures affecting patients and the effect of Medicare inpatient rule changes that have shifted some cases from inpatient to outpatient settings.

Emergency inpatient surgeries, which account for about two-thirds of HCA’s inpatient surgical cases, increased 2% year over year through the first six months. By contrast, elective inpatient surgeries were down 6% this year, compared with a 2% decline in the prior year.

Despite the surgical weakness, Hazen said the company remains encouraged by demand and continues to expect long-term demand growth of 2% to 3%, supported by population growth and market trends in its communities.

Capital Investment and Cost Initiatives HCA has approved more than $7 billion of capital spending expected to come online over the next three years. The investments include 1,000 to 1,200 additional inpatient beds, new hospitals in certain markets, and additional outpatient facilities.

Hazen said the company had approximately 42,000 beds currently in operation, up from roughly 37,000 at the end of 2018. Occupancy increased to 75% from 71% over that period. HCA also had 5% more outpatient sites of care in the second quarter than a year earlier and expects another 250 to 300 outpatient facilities in its capital or acquisition pipeline to open later this year or early next year.

The company spent $1.2 billion on capital expenditures during the quarter, repurchased $2.1 billion of shares and paid $171 million in dividends. Cash flow from operations was $2.3 billion, down 45% year over year, primarily because of the timing of Florida Medicaid supplemental-payment cash flows and the prior-year deferral of federal income tax payments.

HCA maintained its planned 2026 capital expenditure range of $5 billion to $5.5 billion and said it currently expects to complete most of its existing share-repurchase authorization, subject to market conditions and other factors.

On costs, Marks said same-facility cost per equivalent admission, including the effect of Medicaid supplemental payment programs, was essentially flat from a year earlier and improved 1.4% sequentially. He said HCA’s financial resiliency program—which includes digital transformation, global capabilities and expanded shared services—is intended to produce multiyear efficiency benefits. Professional fees remained elevated, rising about 8.5% year over year in the quarter, primarily due to anesthesia and radiology costs.

About HCA Healthcare (NYSE:HCA)HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in HCA Healthcare Right Now?Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends make up large portions of long-term returns, and in many cases, dividend contributions surpass one-third of total returns.

Based in Houston, CenterPoint Energy (CNP - Free Report) is in the Utilities sector, and so far this year, shares have seen a price change of 15.36%. Currently paying a dividend of $0.23 per share, the company has a dividend yield of 2.08%. In comparison, the Utility - Electric Power industry's yield is 3.1%, while the S&P 500's yield is 1.33%.

Looking at dividend growth, the company's current annualized dividend of $0.92 is up 4.5% from last year. Over the last 5 years, CenterPoint Energy has increased its dividend 5 times on a year-over-year basis for an average annual increase of 8.33%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. CenterPoint's current payout ratio is 51%, meaning it paid out 51% of its trailing 12-month EPS as dividend.

CNP is expecting earnings to expand this fiscal year as well. The Zacks Consensus Estimate for 2026 is $1.91 per share, which represents a year-over-year growth rate of 8.52%.

From greatly improving stock investing profits and reducing overall portfolio risk to providing tax advantages, investors like dividends for a variety of different reasons. But, not every company offers a quarterly payout.

Big, established firms that have more secure profits are often seen as the best dividend options, but it's fairly uncommon to see high-growth businesses or tech start-ups offer their stockholders a dividend. Income investors have to be mindful of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, CNP presents a compelling investment opportunity; it's not only an attractive dividend play, but the stock also boasts a strong Zacks Rank of #2 (Buy).

Key Takeaways Unum is expected to benefit from favorable persistency and stronger sales across its insurance businesses. UNM's key operating segments are likely to see growth from voluntary benefits, life and disability products. Unum is expected to face higher expenses, while continued share buybacks may support earnings. Unum Group (UNM - Free Report) is expected to register an improvement in its bottom line but a decline in the top line when it reports second-quarter 2026 results on July 28, after the closing bell.

The Zacks Consensus Estimate for UNM’s second-quarter revenues is pegged at $2.95 billion, indicating a 12.6% decline from the year-ago reported figure.

The consensus estimate for earnings is pegged at $2.14 per share. The Zacks Consensus Estimate for UNM’s second-quarter earnings has moved south by 0.4% in the past 30 days. The estimate suggests a year-over-year increase of 3.3%.

What the Zacks Model Unveils for UNMOur proven model does not conclusively predict an earnings beat for Unum Group this time around. This is because a stock needs to have the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold). This is not the case, as you can see below:

Earnings ESP: Unum Group has an Earnings ESP of -0.89%. This is because the Most Accurate Estimate of $2.13 is pegged lower than the Zacks Consensus Estimate of $2.14. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Zacks Rank: Unum Group currently carries a Zacks Rank #3.

Factors Likely to Shape Q2 Results of UNMFavorable persistency and better sales in the operating segments are likely to have favored premiums in the second quarter. Our estimate and the Zacks Consensus Estimate for premium income are both pegged at $2.6 billion.

Net investment income is likely to have increased due to higher invested assets and higher miscellaneous investment income. Our estimate for investment income is pegged at $297.3 million, suggesting a 47% decrease from the year-ago quarter. The Zacks Consensus Estimate is pegged at $269 million.

The performance of Unum U.S. and Colonial Life — two of the largest operating segments — is likely to have been driven by stable overall persistency in the voluntary benefits and dental and vision product lines, and higher prior period sales in the voluntary benefits product line, improved benefit experience across life, accident, sickness, and disability product lines, and in-force block growth.

Better performance in life and group disability is likely to aid Unum U.S. results.

Our estimate for Unum U.S. operating revenues is pegged at $2 billion, while the same for Colonial Life is pinned at $516.5 million.
Favorable results at group long-term disability, Group Life and Supplemental are likely to have favored Unum UK. This, combined with in-force block growth, sales and favorable overall persistency at Unum Poland, is likely to have benefited Unum International. Our estimate for Unum International’s operating revenues is pegged at $336.1 million.

Expenses are likely to have increased because of higher policy benefits, commissions, interest and debt expense, amortization of deferred acquisition costs and other expenses.

Continued share buybacks are likely to have contributed to the bottom line.

Stocks to ConsiderSome insurance stocks with the right combination of elements to deliver an earnings beat this time around are:

Aflac Incorporated (AFL - Free Report) has an Earnings ESP of +0.34% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 0.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.

AFL’s earnings beat estimates in two of the last four reported quarters and missed in the other two.

The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +2.59% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $5.61, indicating a year-over-year decrease of 5.5%.

ALL’s earnings beat estimates in each of the last four reported quarters.

Axis Capital Holdings Limited (AXS - Free Report) has an Earnings ESP of +3.82% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.23, indicating a year-over-year decrease of 1.8%.

AXS’s earnings beat estimates in each of the last four reported quarters.

While XRP has corrected from the recent $1.16 high, new market data shows that demand in the spot market has continued to improve.

Specifically, buying activity across centralized exchanges has climbed to its highest level in eight weeks, suggesting that many investors are still accumulating XRP despite the latest price decline.

Notably, the latest data also show a growing gap between the spot and derivatives markets. Spot buyers have become more active, while traders in the perpetual futures market continue to favor selling. 

Spot Buying Reaches Its Highest Level Since June Data from July 23 shows that the All CEX Estimated Spot CVD climbed to about $388.6 million, its highest level since June 1. The increase shows a rise in aggressive buying across centralized spot exchanges, showing that buyers have returned to the market in greater numbers.

Meanwhile, the trend looks very different in the derivatives market. Notably, Binance Perpetual CVD remained deeply negative at around -$547.4 million, showing that perpetual futures traders continue to favor the sell side.

XRP CEX Spot CVD and Binance Perpetual CVD | CryptoQuant Also, on Binance, XRP open interest increased from roughly $198 million on July 8 to about $215.7 million on July 23, marking a rise of nearly 9%.

Higher open interest alongside a deeply negative perpetual CVD suggests that traders are opening new leveraged short positions instead of simply closing existing long positions. 

However, open interest alone cannot show the direction of every new position, so it does not tell the full story by itself.

Spot trading also picked up across several major exchanges rather than on just one platform. On July 21, Coinbase recorded around $157 million in XRP spot trading volume, compared with roughly $111 million on Binance. 

This increase suggests that stronger spot demand is spread across multiple exchanges instead of being driven by a single market.

XRP Must Hold Above $1.10 In the short term, XRP continues to trade within a tight range after holding the support around $1.10. Buyers have not yet managed to push the price back above the immediate resistance at $1.11, leaving the token stuck in consolidation.

The current situation suggests that a move below $1.10 could send XRP toward $1.08. On the other hand, a break above $1.11 could open the door for a move to $1.13.

Technical indicators also send mixed signals. The RSI stands at 50, a neutral reading that does not give either buyers or sellers a clear advantage. 

XRP Holding Support However, the MACD still shows a modest buy signal with a reading of 0.001, keeping the bullish case alive. Looking at the broader trend, XRP has gained more than 7% in July and still trades above long-term ascending triangle support. 

If buyers regain control, XRP first needs to break above $1.1642. A successful move beyond that level could open the way to $1.2318 and then $1.2950, with longer-term resistance sitting near $1.4344. For now, holding above $1.10 remains important if bulls want to keep the current recovery attempt alive.

DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.

Bitcoin (BTC) is edging higher on Friday, albeit gradually, after reclaiming support above $65,000. Meanwhile, Ethereum (ETH) shows signs of stability near the immediate $1,900 hurdle, backed by mild capital inflows. Ripple (XRP), on the other hand, holds above the pivotal $1.10, with its upside structurally constrained below $1.15.

Bitcoin ETFs renew outflows as the US-Iran war persistsThe United States (US) has conducted air strikes for a thirteenth consecutive night, with Iranian media reporting explosions in multiple cities, including Khorramabad, Jask, Ahvaz, and Bandar Abbas.

President Donald Trump stated he is weighing a “massive attack” on Iran and will soon determine whether to resume large-scale military operations. Iranian Foreign Minister Abbas Araghchi described the US action as “mindless aggression,” warning that Washington will now face a steeper price to secure an end to the conflict.

Meanwhile, risk-off sentiment is evident among institutional investors, who drew out roughly $225 million from US-listed spot Exchange-Traded Funds (ETFs) on Thursday, following seven consecutive days of inflows. According to SoSoValue data, cumulative inflows stand at $51.63 billion, with net assets at $78.82 billion, underpinning investors' long-term positive BTC outlook.

Bitcoin ETF flows | Source: SoSoValueEthereum spot ETFs continue to recover, with Thursday’s inflows falling to $26 million, from Wednesday’s $73 million. Cumulative inflows edged higher to $11.25 billion from $11.23 billion over the same period, while average assets under management stand at $10.32 billion.

Ethereum ETF flows | Source: SoSoValueAppetite for XRP ETFs has notably lagged that for Bitcoin and Ethereum, with activity remaining muted on Wednesday and Thursday. Looking back, inflows totaled $2.5 million on Monday and roughly $6 million on Tuesday.

According to SoSoValue, cumulative inflows are steady at $1.49 billion, with net assets averaging $1 billion, underscoring investors’ long-term interest in XRP investment products.

XRP ETF flows | Source: SoSoValue“The cryptocurrency market is navigating one of its most complex phases of the year. Bitcoin is no longer driven solely by capital flows or technical indicators; instead, its price action has become a direct reflection of an increasingly intertwined macroeconomic and geopolitical landscape, Simon-Peter Massabni, Head of Business Development at XS.com, said in a comment.

Price analysis: Bitcoin holds higher support Bitcoin trades above $65,000, holding a mildly constructive but still capped tone as price sits above the 50-day Exponential Moving Average (EMA) at roughly $65,150 and the Bollinger Bands’ middle layer near $64,312, while remaining well below the 100-day and 200-day EMAs at about $67,967 and $73,733 respectively.

This configuration suggests an early recovery phase rather than a clean bullish trend, with the Relative Strength Index (RSI) around 55 on the daily chart and the Moving Average Convergence Divergence (MACD) histogram staying comfortably positive, hinting that upside momentum is improving but not yet strong enough to challenge the broader overhead trend filters.

BTC/USDT daily chartOn the topside, initial resistance appears at the upper Bollinger Band around $66,489, where volatility caps the recent bounce, followed by the 100-day EMA near $67,967 and then the more meaningful 200-day EMA around $73,733 as a major medium-term barrier. On the downside, immediate support is provided first by the 50-day EMA at approximately $65,150, with further demand expected at the Bollinger middle band around $64,312. A deeper setback toward the lower band near $62,134 would likely be needed to threaten the nascent constructive bias on the daily timeframe.

Altcoins outlook: Ethereum and XRP show signs a bullish turnaround Ethereum trades at $1,892, holding a neutral-to-bullish tone as price stays above the 50-day EMA near $1,832 and the SuperTrend support around $1,741, but still below the higher-order 100-day and 200-day EMAs. This configuration suggests an ongoing recovery phase within a broader corrective structure, with dip-buying interest emerging above the mid-$1,800s.

The MACD indicator remains in positive territory but has been easing, while the RSI around 58 points to constructive yet not overextended upside momentum.

ETH/USDT daily chartOn the topside, initial resistance appears at the 100-day EMA close to $1,936, and a sustained break above this level would expose the 200-day EMA near $2,183 as the next bullish objective. On the downside, immediate support is defined by the 50-day EMA at roughly $1,832, with a deeper pullback toward the SuperTrend line around $1,741 likely to attract buyers if the current advance pauses or corrects.

XRP, on the other hand, trades at $1.11. The pair remains in a broader bearish context with price holding below the 50-day, 100-day and 200-day EMAs, keeping rallies capped despite the recent rebound from sub-$1.10 levels.

The Parabolic SAR at $1.07 sits underneath spot and suggests nearby trend-follow support, while the RSI hovers around the neutral 50 line on the daily chart, indicating a lack of strong directional conviction as momentum consolidates. The MACD histogram remains marginally positive but is easing, hinting that bullish pressure is waning beneath overhead averages.

XRP/USDT daily chartInitial resistance aligns with the 50-day EMA at $1.14. A daily close above this level would be needed to open the way toward the 100-day EMA at $1.23, with the 200-day EMA higher up at $1.43 reinforcing the medium-term bearish structure. On the downside, immediate support is provided by the Parabolic SAR level at $1.07. A break below this floor would likely expose the pair to a deeper retracement, reinforcing the prevailing downside bias as long as price holds beneath the key EMAs.

(The technical analysis of this story was written with the help of an AI tool. Know more.)

Crypto ETF FAQs An Exchange-Traded Fund (ETF) is an investment vehicle or an index that tracks the price of an underlying asset. ETFs can not only track a single asset, but a group of assets and sectors. For example, a Bitcoin ETF tracks Bitcoin’s price. ETF is a tool used by investors to gain exposure to a certain asset.

Yes. The first Bitcoin futures ETF in the US was approved by the US Securities & Exchange Commission in October 2021. A total of seven Bitcoin futures ETFs have been approved, with more than 20 still waiting for the regulator’s permission. The SEC says that the cryptocurrency industry is new and subject to manipulation, which is why it has been delaying crypto-related futures ETFs for the last few years.

Yes. The SEC approved in January 2024 the listing and trading of several Bitcoin spot Exchange-Traded Funds, opening the door to institutional capital and mainstream investors to trade the main crypto currency. The decision was hailed by the industry as a game changer.

The main advantage of crypto ETFs is the possibility of gaining exposure to a cryptocurrency without ownership, reducing the risk and cost of holding the asset. Other pros are a lower learning curve and higher security for investors since ETFs take charge of securing the underlying asset holdings. As for the main drawbacks, the main one is that as an investor you can’t have direct ownership of the asset, or, as they say in crypto, “not your keys, not your coins.” Other disadvantages are higher costs associated with holding crypto since ETFs charge fees for active management. Finally, even though investing in ETFs reduces the risk of holding an asset, price swings in the underlying cryptocurrency are likely to be reflected in the investment vehicle too.

Japanese spot Bitcoin (CRYPTO: BTC) ETF market could grow to around $18.4 billion by fiscal 2028 under a bullish adoption scenario.

In a July 24 morning edition, Nikkei noted that the estimate is based on the size of Japan’s household financial assets, its investment fund market, participation in the country’s tax-advantaged NISA investment accounts, and existing domestic demand for cryptocurrencies.

Japanese households hold roughly $14.6 trillion in financial assets.

An $18.4 billion Bitcoin ETF market would account for only about 0.13% of that, suggesting that even a relatively small shift in household portfolios could create a sizable market.

It would also represent around 1% of Japan’s public equity investment fund market, which exceeds $1.8 trillion.

The estimate assumes three primary sources of investment demand.

The first would come from existing cryptocurrency investors seeking BTC exposure through a regulated and familiar investment product; the second would be new retail investors; and lastly, wealthy individuals, corporations, and institutional investors making portfolio allocations to Bitcoin.

Access Could Be The Key CatalystThe central argument behind the $18.4 billion scenario is not that Japanese investors will suddenly make large speculative allocations to Bitcoin. Rather, ETF approval could unlock demand by making the asset easier to purchase and hold through financial systems investors already use.

Japanese investors could gain Bitcoin exposure without directly managing wallets, seed phrases, or crypto exchange accounts. That accessibility could be particularly important for institutions and corporations that require regulated custody, reporting and risk-management structures before allocating capital.

In early July, Japanese crypto exchange SBI VC Trade highlighted that registered accounts surpassed 2 million, indicating rising domestic demand for digital assets. The firm said Japanese companies are also increasingly using Bitcoin and XRP (CRYPTO: XRP) in shareholder benefit programs.

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Eight months ago the XRP ETFs launched faster than any product since Ethereum. The bid has since decayed 99%, from $200 million weeks to zero-flow days, leaving $1.49 billion invested, $997 million remaining, and a recovery thesis outsourced entirely to a Senate vote. Here is the full autopsy of a bid, and what its flatline actually prices.

Summary

US spot XRP ETFs launched in November with $667 million in their first month, reaching $1 billion faster than any crypto product since Ethereum’s funds, on an eight-week inflow streak that ran even while Bitcoin funds bled. The bid then decayed by roughly 99%: weekly flows fell from above $200 million to low single-digit millions, the streak ended July 13, and July’s tape shows zero-flow days punctuated by one $7.29 million outflow, the largest since March. The wreckage is precise: $1.49 billion in cumulative inflows now marks against roughly $997 million in net assets, an unrealized deficit near $493 million, with 82% of assets concentrated in three funds and several products flatlined entirely. The one institutional trophy, Goldman Sachs’s $153.8 million position across four funds, is a December-dated 13F snapshot that Bloomberg analysts read as trading-desk facilitation, inside a complex that remains 84% retail-held. The flows have now stabilized at approximately nothing, which the optimistic read calls a floor, and the recovery case has converged on a single external event: the CLARITY Act vote whose odds trade near a coin flip this week. There is a specific moment in the life of every investment product when its story stops being about demand and starts being about anatomy, and for the US spot XRP ETFs that moment can be dated: Monday, July 13, when the daily flow printed zero and an eight-week inflow streak, the product class’s last living narrative, quietly ended. What launched in November as the fastest-growing crypto fund complex since Ethereum’s, $667 million in month one, a billion dollars faster than anyone forecast, institutional validation in fund form, now trades as a case study. The buyers did not rotate, rebalance, or pause. They stopped: from weeks above $200 million to weeks near $2 million, from streak to zero-days, from launch euphoria to a July whose single best session, $6.78 million, amounts to one percent of the early pace. What remains is $1.49 billion of invested capital marking against $997 million of assets, three funds carrying 82% of everything, and a recovery thesis that no longer references the product at all, only a Senate vote. This piece is the full anatomy: how the bid died, what the wreckage precisely looks like, what the lone institutional trophy in the filings actually shows, and what the flatline, honestly read, prices for the asset underneath it.

The decay curve, dated The complex’s eight months divide into three phases so distinct they could belong to different products.

Phase one, the launch bid, ran from November into the winter: $667 million in the first month across seven issuers, the fastest accumulation to $1 billion since Ethereum’s funds, weekly prints above $200 million, and the statistic the marketing decks will never retire, an inflow streak that persisted through weeks when Bitcoin ETFs bled, which was read at the time as evidence of a distinct, durable XRP allocator base. The reading had support: the products launched into the afterglow of the SEC’s surrender, the commodity classification, and the first wave of bank-desk research initiating coverage with conditional price targets in the double digits.

Phase two, the decay, occupied the spring: weekly flows stepped down from nine figures to eight to seven, May still collected over $100 million for the month, and by June the run-rate had thinned to low single-digit millions per week, a decline of roughly 99% from peak that no single event explains and one variable tracks perfectly, the token’s price, which fell from above $2.40 in January to the $1.10s, converting every earlier allocation into a loss and every allocator’s quarterly review into an uncomfortable meeting. Fund flows follow performance with a lag in both directions; the launch streak was the up-lag, and the decay was the down-lag arriving on schedule.

Phase three, the flatline, is July: six sessions of exactly zero flows in the month’s first half, a $7.29 million single-day outflow on July 9, the largest since March, the streak’s formal end on July 13, then a stretch from July 10 through July 20 of zeros and small positives, crowned by the month’s best day, $6.78 million on July 16, driven by two issuers’ desks. The freshest coverage frames the stabilization as survival, the product has not seen an outflow day since July 9, and the framing is technically true and proportionally absurd: the bid that defined the launch is not resting, it is absent, and its absence has become stable. That is what the anatomy shows. The interesting questions are in the tissue.

The wreckage, itemized Four numbers, current as of this week’s data, describe the complex more honestly than any narrative.

$1.49 billion against $997 million. Cumulative net inflows since launch stand near $1.49 billion; total net assets stand near $997 million, roughly 1.45% of XRP’s market capitalization, with about 971 million XRP in custody. The gap, approximately $493 million, is the unrealized loss the allocator base collectively carries, the arithmetic consequence of buying a token averaging well above $1.50 that now trades near $1.10. Every future flow decision the complex’s holders make is made against that deficit, which is the single most important fact in any forecast of the flows resuming: the marginal buyer is being asked to average down into a product whose existing buyers are 33% underwater on invested capital.

82% in three funds. Bitwise holds $312.8 million in assets on $498.3 million of cumulative inflows; Canary $253.2 million on $467.0 million; Franklin $252.2 million on $415.6 million. Together, the top three hold roughly 82% of complex assets, which means the seven-fund complex is functionally a three-fund market with a long tail of products printing zeros. Category-level flow headlines obscure this: an inflow day increasingly means one or two distribution desks had a decent Thursday, and a diversified institutional bid, the launch thesis, would not produce this shape.

84% retail-held. The complex’s ownership base, per the issuer-side analysis that accompanied the spring’s institutional reporting, remains 84% retail, against 48.8% institutional participation in the comparable Solana products, a gap that quantifies how much of the launch narrative, the institutions are here, was distribution, not description. Which frames the trophy correctly.

The Goldman position, read properly. Goldman Sachs’s 13F disclosed $153.8 million across four XRP funds, roughly $40 million in Bitwise, $38.5 million in Franklin, $38 million in Grayscale, $36 million in 21Shares, making it the largest disclosed institutional holder, accounting for 73% of the top 30 institutions’ combined $211 million. The number did real narrative work all spring, and its caveats are the anatomy lesson: it is a December 31 snapshot, disclosed in March, of positions that may not exist today; Bloomberg’s analysts read the four-fund construction as consistent with trading-desk facilitation and client positioning instead of proprietary conviction; and as this publication’s own guide to how to read the Goldman position argues, the form is a rear-view mirror with a 45-day delay, structurally incapable of showing whether the bank held, added, or exited through the subsequent drawdown. The largest institutional XRP position on record is, read strictly, evidence that Goldman’s clients wanted exposure in December. The flows since are evidence of what everyone wanted after.

The geography of the remaining bid One more layer of the anatomy deserves its own examination, because the aggregate US flow numbers conceal a compositional fact with real information in it: through the American flatline, the marginal bid for exchange-traded XRP exposure migrated abroad.

Through the spring decay, European venues carried a share of global XRP product flows out of proportion to their size, with Swiss and broader European ETP wrappers at times representing the substantial majority of weekly net inflows worldwide while the US complex printed its zeros. The absolute sums are modest, European crypto ETPs are an older, smaller, steadier market, but the composition matters for what it falsifies and what it suggests. It falsifies the strongest form of the exhaustion reading: if the asset’s entire allocator universe were fully purchased, the European bid would have flatlined alongside the American one, and it did not. And it suggests where the marginal buyer actually lives: in jurisdictions where the asset’s legal status was never contested, where MiCA-era frameworks settled classification questions years earlier, and where the products consequently trade as ordinary alternatives allocations, not as bets on a Senate calendar.

Read that way, the geographic split becomes the cleanest natural experiment available on the outsourced thesis. The American flows died in the jurisdiction where the asset’s status remains hostage to legislation; the European flows persisted, modestly, in jurisdictions where it does not. If legal permanence is truly the binding constraint on institutional allocation, the CLARITY experiment has already run abroad, and its result, steady but unspectacular demand, prices the upper bound of what passage realistically unlocks: not the JPMorgan-forecast flood, but a normalization to the European pattern, mid-single-digit millions weekly, compounding quietly, unheroically, forever. That is a real bull case, and it is a fraction of the one being marketed.

The alternative reading restores the American market’s exceptionalism: US wealth-management distribution is an order of magnitude deeper than Europe’s, the RIA channel that turned Bitcoin’s ETFs into a $52 billion complex has no European equivalent, and the launch month’s $667 million showed what that distribution can move when it has a story to sell. On this reading, Europe measures the floor of post-CLARITY demand and America’s launch month measured the ceiling, and the truth, as usual, books a room between them. Either way, the geographic ledger deserves a place in every flow analysis this complex receives, because it is the one dataset showing what XRP demand looks like when Washington is not the variable, and it has been quietly reporting that answer, in Swiss francs, all year.

The regulated-channel counterpoint One dataset complicates the pure decay story, and honesty requires it: while the spot complex flatlined, the regulated derivatives channel set records.

CME’s XRP futures built to a peak of $1.4 billion in open interest with 29 large open-interest holders, a record for the venue, even as total XRP derivatives open interest across all venues collapsed from its $10 billion peak by margins reported between 75% and 96%, a deleveraging that wiped out the offshore, retail-levered complex. The split matters because the two channels answer different questions: aggregate open interest tracks speculative leverage, which is gone, while CME positioning tracks the institutions that clear through Chicago, which grew through the wreckage. The honest synthesis is narrower than either headline: the levered retail market deflated, a smaller regulated market matured, and neither flow bought spot tokens, which is why the ETF shelf and the price both starved while the derivatives venue celebrated. Institutional infrastructure and institutional demand are different things, a distinction this asset’s whole history keeps teaching. For the underlying distribution picture, crypto.news has also mapped the supply map under the products.

What the flatline prices Strip the anatomy to its meaning and three readings compete, with the tape currently endorsing the bleakest.

The floor reading, the optimists’ case, holds that the shakeout is complete: outflows never cascaded, the post-July 9 tape shows zero net redemption, the deficit is carried rather than capitulated, and a stabilized base at $1 billion of assets is the platform a catalyst builds on. Its evidence is real, the complex genuinely did not unwind the way GBTC-era products did, and its weakness is that a floor with no bid above it is just a ledge.

The exhaustion reading holds that the launch consumed the entire natural buyer base: the crypto-native allocators, the RIA early adopters, and the bank desks servicing client curiosity all bought in the first two quarters, at prices 40% above the current market, and no second cohort exists at any price the first cohort’s losses will allow advisers to recommend. On this reading the flatline is not a floor but a completed distribution, and the zero-days are what a fully-sold product looks like.

And the outsourced reading, the one the complex’s own defenders now lead with, holds that the flows return when Washington acts: legal permanence unlocks the institutional allocation the launch never actually contained, the 84% retail share inverts, and the JPMorgan-style first-year forecasts the complex undershot get a second life under a market-structure law. This is the reading that matters, because it is the one being priced, and its honest form is uncomfortable: it concedes the product failed to generate durable demand on its own and converts the entire recovery case into a claim about one bill, whose cloture count stands unresolved this very week, whose passage odds trade near a coin flip, and whose own conditional structure, as this publication’s analysis of the conditional targets riding these flows showed, was already the load-bearing wall under every double-digit XRP forecast. The ETF complex, the price targets, and now the flow-recovery thesis have all converged on the same single point of failure. That is not diversification of catalysts. It is concentration, in a legislature, measured at 41% on Polymarket, and the flatline is what an asset looks like while it waits on it.

What to watch The weekly prints against the zero line. The complex has proven it can avoid outflows; the open question is whether anything above $10 million a week ever returns without a legislative trigger. Sustained mid-eight-figure weeks would falsify the exhaustion reading on their own.

The concentration ratio. Watch whether the three-fund share of assets rises above 82%, consolidation continuing, or whether the tail products show life, the only clean signal of a broadening buyer base instead of two sales desks working.

The CLARITY binary, and the day after. Passage would run the outsourced thesis’s experiment in real time: the flows either arrive within weeks, validating everything, or they do not, which would be the most damaging data point in the asset’s institutional history, because it would exhaust the last explanation. Failure of the bill runs the mirror experiment on the deficit’s holders. That is the event the recovery thesis waits on.

The Q1 13F cycle’s ghosts. The May filings covering the drawdown quarter will show whether Goldman and the top-30 cohort held through the decline. A largely intact institutional roster supports the floor reading; a vanished one completes the anatomy.

Eight months ago the XRP ETFs were the proof that institutional demand existed. The anatomy shows what they actually proved: that distribution existed, that a launch window monetized it, and that demand, the durable kind that buys drawdowns, was never located. The complex now holds $997 million, a $493 million scar, and one hypothesis left to test, scheduled for a Senate floor that has not yet set the time. Products usually die of redemption. This one’s fate is stranger: fully built, fully priced, and waiting, with the rest of its asset class, for Washington to tell it whether the buyers were ever real. For context, crypto.news has explained he flow machinery itself.

Frequently asked questions What happened to the XRP ETF inflows? They decayed roughly 99% from launch. The products drew $667 million in their first month from November and sustained an eight-week inflow streak, but weekly flows fell from above $200 million to low single-digit millions by summer. The streak ended July 13, July logged six zero-flow sessions and a $7.29 million outflow day, and the month’s best session brought just $6.78 million.

How much money is in the funds now, and what is the loss? Cumulative net inflows stand near $1.49 billion, while total net assets are roughly $997 million, about 1.45% of XRP’s market capitalization, with approximately 971 million XRP in custody. The gap of roughly $493 million represents unrealized losses on invested capital, reflecting purchases made at substantially higher token prices than the current $1.10 area.

Which funds dominate the complex? Three of seven: Bitwise with $312.8 million in assets, Canary with $253.2 million, and Franklin with $252.2 million, together roughly 82% of all complex assets. The remaining products frequently print zero daily flows, meaning category-level inflow headlines usually reflect activity at one or two distribution desks, not broad-based demand.

Does Goldman Sachs’s position change the picture? Less than headlines suggested. Goldman’s $153.8 million across four funds, disclosed in its Q4 2025 13F, made it the largest institutional holder, about 73% of the top 30 institutions’ combined exposure. But the filing is a December 31 snapshot published in March, Bloomberg analysts read the construction as trading-desk facilitation rather than directional conviction, and the complex overall remains 84% retail-held.

How does the CME futures record fit the story? As a counterpoint about a different market. CME’s XRP futures reached a record $1.4 billion in open interest with 29 large holders even as total XRP derivatives open interest collapsed as much as 96% from its $10 billion peak. The regulated channel matured while offshore leverage deflated, but neither development bought spot tokens, which is why the ETF flows and the price starved simultaneously.

Is the recent stabilization a positive signal? It is the debated question. Since the July 9 outflow, daily flows have been zero or slightly positive, no redemption cascade has occurred, and the deficit is being carried rather than capitulated, the floor reading. The skeptical reading calls the same tape exhaustion: the natural buyer base fully purchased during launch and no second cohort exists at current prices. The flatline is consistent with both until something moves.

Why does everything now depend on the CLARITY Act? Because every other catalyst has been consumed. The SEC resolution, the launches, and the bank coverage all occurred, and the flows died anyway, leaving legal permanence as the last untested explanation for why institutional allocation has not arrived. The recovery thesis for the flows, the analyst price targets, and the asset’s broader institutional case have converged on the same legislative binary, currently priced near a coin flip.

What should investors watch next? Weekly flows against the zero line, with sustained mid-eight-figure weeks as the falsifier of the exhaustion reading; the three-fund concentration ratio, for any sign of a broadening base; the Q1 13F filings covering the drawdown quarter, to see whether the institutional roster held; and the CLARITY vote itself, whose aftermath in either direction runs the decisive experiment on whether the buyers return. This is not investment advice.

Disclaimer: This article is for information and educational purposes only and does not constitute financial or investment advice. Flow figures and asset values change daily and reflect data available at the time of writing. Nothing here is a recommendation to buy, sell, or hold any asset or fund. Always do your own research. Information is accurate as of July 24, 2026.

The XRP ecosystem has welcomed over $800 million worth of distributed real-world assets this year amid the growing tokenization trend on the network.

The tokenization market has continued to grow in 2026, with its total value now exceeding $410 billion. Current data puts the market at $410.70 billion, made up of $36.72 billion in distributed asset value and $373.98 billion in represented asset value.

Growth has been especially strong in the distributed asset segment. At the beginning of the year, distributed asset value, excluding stablecoins, stood at $25.39 billion. It has since risen to $36.72 billion, as interest in tokenization has gained momentum throughout the year.

XRPL Adds Over $800 Million in Distributed RWA The XRP Ledger has also benefited from the growing interest in tokenized assets. As more attention has moved toward the sector, the network has expanded the value of assets issued directly on the ledger.

Data shows that the XRP Ledger now holds $1.319 billion in distributed asset value when stablecoins are included. Without stablecoins, the figure stands at just $323.18 million.

The network began 2026 with $518 million in distributed real-world assets. Since then, that figure has climbed to $1.319 billion, meaning the XRP Ledger has added exactly $801 million in distributed RWAs this year. The increase shows the network’s growing role in the broader tokenization market.

Distributed RWA on XRP Ledger RLUSD Leads the Growth Ripple’s stablecoin, RLUSD, has driven most of the increase in distributed assets on the XRP Ledger. At the start of the year, RLUSD had a market capitalization of $235 million. It has since grown to $896 million, adding $661 million in value during 2026.

Ripple has supported this growth by increasing RLUSD minting on the XRP Ledger while burning more of the stablecoin on Ethereum. As a result, RLUSD now makes up 67.96% of the XRP Ledger’s total distributed asset value.

The stablecoin ecosystem on the network has also continued to expand. Combined stablecoin market capitalization on the XRP Ledger has reached $995 million, bringing it close to the $1 billion mark. 

Alongside RLUSD, Braza USDB contributes $69.44 million, BBRL accounts for $12 million, and USDC adds $5.8 million, with several other stablecoins making up the remainder. These assets have played an important role in increasing the ledger’s distributed asset value.

Total RWA on XRP Reaches $5.35 Billion The XRP Ledger’s tokenized asset ecosystem extends beyond distributed assets. When represented asset value is included, the network now supports $5.35 billion in real-world assets, including stablecoins.

Several tokenized products account for much of that value. The largest is JMWH from Justoken, which is worth $2.229 billion. RLUSD follows with $876 million, while the Ondo Short-Term US Government Bond Fund contributes $222 million. The ASENA FIF – Single Tranche product also represents a significant share with $215.7 million.

These figures confirm how quickly the XRP Ledger’s tokenized asset ecosystem has expanded this year. RLUSD has led the growth in distributed assets, while several large tokenized financial products have strengthened the network’s represented asset value.

DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.

XRP could be repeating the same price pattern that came before its massive rally in the 2017/2018 market cycle. 

Latest market data suggests the asset is again moving within a symmetrical triangle, similar to the structure that eventually led to a remarkable 66,000% gain and pushed XRP to $3.31 nine years ago.

The first version of this symmetrical triangle played out over several years. Specifically, it started after XRP fell from its $0.0614 high in December 2013 and continued until the breakout in March 2017. 

Once XRP broke above the pattern, an impressive rally ensued. The token climbed more than 66,000%, rising from around $0.005 in March 2017 to a peak of $3.31 in January 2018.

XRP Has Formed A Bigger Triangle The current symmetrical triangle is larger and took much longer to develop than the previous one. Unlike the first pattern, this one has formed over an entire market cycle.

This second triangle started forming after XRP dropped from its $3.31 peak in January 2018. The asset remained inside the pattern for years before finally breaking above the upper resistance line. 

XRP broke above the triangle’s main resistance line during the Trump-led November 2024 rally. The breakout triggered a strong move higher, sending the asset from about $0.5 to $3.4 by January 2018. After the rally, XRP pulled back before climbing again to a new all-time high of $3.6 in July 2025.

XRP Triangle Structure Notably, the rally did not continue immediately after reaching that peak. Instead, XRP entered a deep correction that brought it back toward the previous breakout area and rising macro support. This phase represents an important test of the long-term structure, as XRP currently remains in this broader downtrend.

RSI Shows Oversold Conditions Despite the ongoing weakness, one key momentum indicator has moved into an area that previously marked strong accumulation zones. 

Notably, the monthly Relative Strength Index (RSI) has dropped into oversold territory at 41.85, near levels where XRP has historically attracted long-term buying interest.

Currently, the price remains weak, market sentiment has become exhausted, and much of the previous rally has faded. 

However, the broader breakout structure has not been invalidated. Importantly, traders should prepare for continued volatility, more testing of support, and a difficult path back upward instead of an immediate recovery.

History Suggests a Key Support Level XRP’s current situation resembles what happened after the March 2017 breakout. Following that breakout, XRP dropped to $0.0075 in April 2017. The sudden decline brought the price back to the upper trendline of the triangle, allowing it to complete a successful breakout retest.

After finding support there, XRP resumed its rally and eventually reached $3.31 by January 2018. If buyers defend the present support area this time, the decline could become a normal post-breakout reset instead of the beginning of a larger structural breakdown.

The most important support zone now sits between $0.70 and $0.83, with $0.82 standing out as the key level. This area lines up with the upper trendline of the symmetrical triangle. Holding above that range would help XRP stay above the breakout level and keep the long-term bullish structure intact.

DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.

Key Takeaways Liquidia's Yutrepia launch has driven strong sales, adoption and three straight profitable quarters. LQDA projects far faster 2026 revenue and EPS growth, backed by rising earnings estimates.United Therapeutics counters with a broad PAH portfolio and late-stage ralinepag pipeline. Liquidia Corporation (LQDA - Free Report) is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

United Therapeutics (UTHR - Free Report) boasts six FDA-approved therapies that treat PAH, PH-ILD, and neuroblastoma, a rare pediatric cancer, in its portfolio.

Liquidia and United Therapeutics are locked in a fierce battle in the PAH market, with Liquidia's Yutrepia emerging as a challenger to United Therapeutics' blockbuster Tyvaso franchise. Their competition extends beyond commercial sales to patent disputes and a race to capture a larger share of the inhaled treprostinil market.

Given this backdrop, selecting one stock over the other can be difficult. We therefore evaluate their fundamentals, growth prospects, challenges and valuation metrics to help make an informed decision.

The Case for LQDALiquidia currently markets Yutrepia (treprostinil) inhalation powder, approved by the FDA in May 2025 and launched the following month commercially.

The company also generates revenues through a profit-sharing agreement with Sandoz for the promotion of its generic treprostinil injection in the United States.

Yutrepia is an inhaled dry-powder formulation of treprostinil developed using Liquidia's proprietary PRINT particle engineering technology. The platform is designed to enhance deep lung drug delivery, simplify administration through a low-effort dry-powder inhaler and enable higher dose levels than currently marketed inhaled treprostinil therapies.

The company supports commercialization through a specialized sales force focused on physicians treating PAH and PH-ILD, as well as stakeholders involved in reimbursement and drug distribution.

Since its launch in June 2025, Yutrepia has emerged as a strong growth driver, generating approximately $130 million in first-quarter 2026 sales. The therapy has demonstrated robust adoption, with more than 4,500 unique prescriptions, around 3,750 patients initiating treatment, and nearly 1,000 physicians prescribing the drug.

Its rapid uptake helped Liquidia post its third consecutive profitable quarter, highlighting Yutrepia's growing commercial success.

Beyond its commercial portfolio, Liquidia is advancing a pipeline of therapies for pulmonary vascular diseases. Its lead pipeline candidate, L606, is an investigational liposomal formulation of treprostinil administered twice daily via a next-generation nebulizer. L606 is being evaluated in an open-label study for PAH and PH-ILD, while a global pivotal placebo-controlled trial is underway in PH-ILD.

Liquidia also plans to expand Yutrepia into additional indications, including pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD), idiopathic pulmonary fibrosis (IPF), progressive pulmonary fibrosis (PPF) and Raynaud's phenomenon associated with systemic sclerosis.

The Case for UTHRUnited Therapeutics markets a broad PAH portfolio led by Tyvaso DPI, a dry-powder inhaled formulation of the prostacyclin analogue treprostinil, which was approved by FDA in May 2022 to improve exercise ability in patients with PAH and PH-ILD.

Its portfolio includes nebulized Tyvaso, a nebulized liquid inhaled formulation of treprostinil, approved by the FDA to improve exercise ability in patients with PAH and PH-ILD.

The company also markets Remodulin, a continuously infused treprostinil therapy for PAH administered subcutaneously or intravenously, supported by the user-friendly RemunityPRO infusion pump. Its PAH portfolio further includes Orenitram, an oral extended-release treprostinil tablet, and Adcirca (tadalafil), an oral PDE-5 inhibitor licensed from Eli Lilly through the end of 2026.

Sales of Tyvaso products continue to grow, driven by higher volumes and continued growth in commercialization utilization. Moreover, Orenitram offers a convenient oral treatment option that avoids the challenges associated with continuous infusion therapies, such as Remodulin, and inhaled therapies requiring multiple daily administrations.

The company remains focused on developing additional therapies for PAH and pulmonary fibrosis (PF).

Ralinepag, an investigational, highly selective and potent prostacyclin (IP) receptor, is one of United Therapeutics' most promising late-stage pipeline assets. The candidate is being developed in two formulations — an oral version and a DPI version (RAL-DPI).

Based on positive data from the pivotal phase III ADVANCE OUTCOMES study, United Therapeutics intends to submit a new drug application for ralinepag (to treat PAH) to the FDA by the second half of 2026.

If approved, oral ralinepag could strengthen United Therapeutics’ leadership in PAH and potentially offset future competitive pressure on older products.

Beyond the oral formulation, United Therapeutics is also developing inhaled dry-powder versions of ralinepag, RAL-DPI, in collaboration with MannKind Corporation. While initially targeting PAH, management sees opportunities for RAL-DPI in PH-ILD, IPF and PPF. Together, the oral and inhaled formulations position ralinepag as a potential cornerstone of United Therapeutics' future growth strategy.

Outside its PAH franchise, the company markets Unituxin for the treatment of high-risk neuroblastoma.

UTHR strengthened its long-term regenerative medicine strategy by acquiring preclinical stage biotech Thymmune Therapeutics for $140 million upfront, with up to $160 million in milestone payments. The deal adds THY-100, a stem cell-derived thymic cell therapy being developed for congenital athymia, and a platform with potential applications in organ transplantation, autoimmune diseases and immune deficiencies.  The acquisition broadens United Therapeutics' pipeline beyond PAH.

A Look at Estimates: LQDA versus UTHRThe Zacks Consensus Estimate for LQDA’s 2026 sales implies a year-over-year increase of 315.77%, while that for earnings per share (EPS) suggests a year-over-year improvement of 477.5%. The Zacks Consensus Estimate for 2026 EPS has moved north to $3.02 from $2.97 and that for 2027 EPS has increased to $4.92 from $4.81 in the past 60 days.

LQDA’s Estimate Movement
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for UTHR’s 2026 sales implies a year-over-year increase of 1.46%, while that for EPS suggests a year-over-year decline of 4.41%.  EPS estimates for 2026 have moved south to $26.63 in the past 60 days but those for 2026 have moved north to $31.66 from $31.09 during the said time frame.

UTHR’s Estimate Movement
Image Source: Zacks Investment Research

Price Performance and Valuation of LQDA and UTHRFrom a price-performance perspective, LQDA has fetched better returns than UTHR so far in the year. Shares of LQDA have surged 158.2%, while those of UTHR have gained 8.7%. The industry has gained 1.4% in the said period.

Image Source: Zacks Investment Research

From a valuation standpoint, LQDA is more expensive than UTHR. LQDA’s shares currently trade at 8.74X forward sales, higher than 6.50X for UTHR.

Image Source: Zacks Investment Research

Which Stock Is a Better Pick for Now?LQDA currently sports a Zacks Rank #1 (Strong Buy), while UTHR carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Although United Therapeutics remains the established leader in PAH with a diversified portfolio, a robust late-stage pipeline and expansion into regenerative medicine, much of its growth appears incremental.

In contrast, Liquidia is in the early stages of a rapid commercial expansion, driven by the impressive launch of Yutrepia, expanding label opportunities and a promising pipeline. The company's superior revenue and earnings growth outlook, upward estimate revisions, stronger year-to-date share price performance and better Zacks Rank outweigh its premium valuation.

While UTHR remains a solid long-term holding, Liquidia offers the more compelling growth story and greater upside potential at current levels, making LQDA the better pick for investors seeking higher returns.

EGRAG CRYPTO, a respected technical analyst in the XRP ecosystem, has reflected on the rapid evolution of both XRP and its community since the early days of the cryptocurrency. His recent analysis emphasizes the asset’s journey from minimal technical scrutiny to frequent coverage by an expanding group of experts.

The Analyst Landscape Has ShiftedEGRAG CRYPTO noted that when the XRP Ledger launched in 2012, dedicated technical analysis around the asset was extremely limited. By 2018, he was already privately analyzing XRP and Bitcoin, focusing on structures such as Fibonacci levels, moving averages, and market cycles. At the time, few analysts publicly applied advanced tools like Elliott Wave and Wyckoff methodology to XRP.

By 2021, when he began sharing his insights openly, EGRAG CRYPTO had become one of the earliest public commentators to consistently produce technical analysis for the XRP community. Since then, the landscape has diversified significantly. More analysts have entered the space, studying XRP’s price action and long-term trends using various technical approaches.

Many now apply distinct methods and may disagree about short-term movements, but a growing number of analysts often reach similar long-term conclusions regarding XRP’s structural outlook.

He believes that this diversity of opinion, coupled with recurring structural patterns identified by independent analysts, strengthens overall understanding and community resilience. For him, the presence of respectful debate helps sharpen analytical frameworks and transforms conviction into informed conviction.

A Timeline Built on StagesIn his post, EGRAG CRYPTO outlined a progression in XRP’s growth. The journey began with fundamentals, advanced through a period dominated by a handful of technical analysts, and has now reached a phase of broad-based public sharing among a larger expert group.

He projects that the next phase will focus on global adoption, anticipating that institutions, banks, corporate entities, developers, and individuals around the world will increasingly utilize XRP and the XRP Ledger for practical use cases.

Mini dictionary: The XRP Ledger is an open-source, decentralized blockchain developed by Ripple for fast and cost-effective cross-border payments. Its consensus mechanism allows quick transaction settlement without mining.

Supporting this outlook, EGRAG CRYPTO shared an illustration depicting a timeline from 2012 through 2076 and beyond. The visual summarizes growing community participation and envisions a future where XRP use spans the globe.

Consistency of VisionThroughout his years covering XRP, EGRAG CRYPTO has maintained a consistent analytical approach even when few paid attention to the asset. Today, he observes others building on some of the foundational ideas he recognized years ago.

He concludes by expressing optimism about the direction of the community, stating that joint learning and collaboration will pave the way for future growth.

Together, we study. Together, we learn. Together, we rise.

Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

Signature Youth Initiative Anchors the Second Annual Impacting the Carolinas Campaign; First Horizon Bank Named Presenting Partner of Bee-Ball For All

, /PRNewswire/ -- The Charlotte Hornets have announced First Horizon Bank (NYSE: FHN or "First Horizon") as the presenting partner of Bee-Ball for All, the organization's signature youth engagement platform and cornerstone of the second annual Impacting the Carolinas initiative. Through Bee-Ball for All presented by First Horizon Bank, the Hornets will distribute 10,000 basketballs to youth through participating Boys & Girls Club locations across North and South Carolina, expanding access to the game while creating opportunities for mentorship, literacy, wellness and community engagement throughout the region.

First Horizon Bank and Charlotte Hornets Bee-Ball for All Event - Northridge Middle School, Charlotte NC To officially tip off the initiative, Hornets, First Horizon Bank and Boys & Girls Club leaders – along with Hornets Legend Muggsy Bogues – gathered at Northridge Middle School on Thursday, July 23 for a formal announcement and youth basketball clinic celebrating the launch of the two-state distribution effort. The event served as the beginning of a broader effort that will place 10,000 basketballs into the hands of children across North and South Carolina.

"This isn't just about giving away basketballs; it's about opening doors for youth development in multiple ways," said Justin Rutledge, Senior Vice President and Charlotte Market President for First Horizon Bank. Laura Bunn, Executive Vice President and Mid-Atlantic Regional President for First Horizon Bank added, "Sports also build teamwork, discipline and skills youth will carry through their lives. While we're proud to celebrate in Charlotte today, the mission reaches far beyond this community. Bee-Ball for All helps us connect with youth across the Carolinas, so opportunities aren't limited to one city, but shared across more than 200 Boys & Girls Clubs spanning North and South Carolina."

"Partnerships like this allow us to make a greater impact than we ever could alone. We are incredibly grateful to First Horizon Bank for sharing our commitment to investing in youth and strengthening communities throughout the Carolinas," said Hornets Sports & Entertainment Senior Vice President of Community Impact Betsy Mack. "Together, we are creating opportunities for young people to grow, learn, build confidence and connect through the game of basketball."

Launched in 2025, Impacting the Carolinas is designed to strengthen Hornets Sports & Entertainment's community impact and regional presence across North and South Carolina while reinforcing the organization's commitment to being the Team of the Carolinas.

About First Horizon
First Horizon Corp. (NYSE: FHN), with $84.4 billion in assets as of June 30, 2026, is a leading regional financial services company, dedicated to helping our clients, communities and associates unlock their full potential with capital and counsel. Headquartered in Memphis, TN, the banking subsidiary First Horizon Bank operates in 12 states concentrated in the southern U.S. The Company and its subsidiaries offer commercial, private banking, consumer, small business, wealth and trust management, retail brokerage, capital markets, fixed income, and mortgage banking services. First Horizon has been recognized as one of the nation's best employers by Fortune and Forbes magazines and a Top 10 Most Reputable U.S. Bank. More information is available at www.FirstHorizon.com.

About Hornets Sports & Entertainment
Hornets Sports & Entertainment (HSE) owns the Charlotte Hornets and the Greensboro Swarm (NBA G League), and operates Spectrum Center, the premier destination for sports and entertainment in the Carolinas. Charlotte's first professional sports team, the Hornets joined the NBA in 1988 and are a member of the Eastern Conference's Southeast Division. HSE is committed to positively impacting the Carolinas through community programming and the Charlotte Hornets Foundation. Spectrum Center is celebrating its 20th anniversary and reopened following a two-phased renovation as a fully transformed world-class arena in the heart of Uptown Charlotte. Through the years, Spectrum Center has hosted nearly 2,500 events and has welcomed more than 25 million guests. Directly across from Spectrum Center, the state-of-the-art Novant Health Performance Center is being built to enhance player development and foster a culture of high performance. 

For more information, please visit hornets.com, gsoswarm.com or spectrumcentercharlotte.com

SOURCE First Horizon Bank

XRP Price Falls as CLARITY Act Nears Make-or-Break Deadline: What’s Next?

Table of contents

Page Last Reviewed: July 24, 2026

Most major cryptocurrencies are trading lower on July 24, 2026, with Bitcoin down 0.85% to $65,104.61 and sharper declines across Ethereum, XRP, and Solana, all off more than 2%. Two forces are compounding today: a broader risk-off move across financial markets tied to rising oil prices and escalating US-Iran military tensions, and fading confidence in the CLARITY Act’s path through the US Senate, with prediction-market odds for 2026 passage falling to 38% from 46% just a day earlier.

Key Takeaways Crypto is trading broadly lower today, with Bitcoin down 0.85% and sharper declines of more than 2% across Ethereum, XRP, and Solana. Rising oil prices tied to escalating US-Iran military tensions have pushed Treasury yields higher and pressured risk assets broadly, including crypto and equities like the Nasdaq. The CLARITY Act’s Senate outlook has darkened, with prediction markets cutting implied 2026 passage odds to 38% after Senate Democrats criticized the latest draft’s ethics and consumer-protection language. Dogecoin (DOGE) is down more sharply than other majors today, continuing its pattern of amplifying broader market moves in both directions. Not every asset is down — Monero (XMR) remains up sharply for the week, a reminder that today’s decline isn’t uniform across the entire market. Today’s Main Drivers Macro pressure and geopolitical risk. Oil prices have surged toward $88.60 a barrel amid escalating US military action linked to Iran, pushing Treasury yields higher and dampening risk appetite across both crypto and equities — the Nasdaq fell over 2% this week on the same pressures. This kind of broad risk-off move tends to hit crypto alongside, not separately from, traditional risk assets.

CLARITY Act uncertainty deepens. The bill’s Senate outlook, which looked genuinely promising just days ago on reports of a White House ethics-package agreement, has darkened after Senate Democrats criticized the latest draft as insufficient on ethics and consumer protections. Senate Majority Leader John Thune has acknowledged the bill will likely miss its pre-recess deadline, and prediction markets have responded by cutting implied 2026 passage odds to 38%. For the fullest picture, see Crypto News Today and Crypto Market Today.

Other Factors Worth Noting Uneven declines across assets. Dogecoin is down more sharply than Bitcoin or Ethereum today, consistent with its history of amplifying broader market moves in both directions due to lower relative liquidity and a heavily retail trading base.

Monero moving against the trend. XMR remains up sharply for the week even as most of the market pulls back, a reminder that today’s decline reflects broad market pressure rather than a uniform, asset-by-asset sell-off.

Bitcoin ETF inflows remain positive. Despite today’s price action, Bitcoin ETFs have logged seven consecutive days of net inflows — a genuinely supportive signal that institutional demand hasn’t broken down alongside the price pullback.

Is This a Bad Sign, or Normal Volatility? Today’s declines, while broader than some recent sessions, remain within the range of normal crypto volatility. Bitcoin is still up 3.58% for the week despite today’s drop, and the immediate catalysts — oil prices, geopolitical tensions, and a specific legislative timeline — are identifiable rather than mysterious. That said, the combination of deteriorating CLARITY Act odds and rising macro pressure is a genuine, not merely cosmetic, shift from the more optimistic mood earlier in the week, and it’s worth taking seriously rather than dismissing as routine noise.

What Would Reverse Today’s Trend? A CLARITY Act stabilization. Any sign that Senate leadership has found a path to address Democrats’ ethics and consumer-protection concerns, or confirmation that floor action will begin before the recess, would likely ease some of today’s regulatory-driven pressure.

Easing geopolitical tensions. A de-escalation in US-Iran military tensions and a pullback in oil prices would remove one of the two compounding pressures currently weighing on risk assets broadly.

Continued ETF inflows. An eighth consecutive day of Bitcoin ETF inflows would reinforce the case that institutional demand remains intact despite today’s price weakness and darkening regulatory outlook.

This article is for informational purposes only and does not constitute financial advice. Always conduct independent research before making investment decisions.

Frequently Asked Questions Why is Bitcoin down today specifically? Bitcoin is down 0.85% today as rising oil prices tied to US-Iran tensions and fading CLARITY Act passage odds combine to pressure risk assets broadly across the market. It's a genuine shift from the more optimistic mood earlier in the week, though BTC remains up 3.58% for the week despite today's decline.

Is today's crypto dip something to worry about? The decline is broader than some recent sessions but still falls within normal volatility ranges, and Bitcoin remains up for the week overall. The underlying catalysts — oil prices, geopolitical tensions, and a specific legislative timeline — are identifiable and worth monitoring rather than dismissing, but don't yet signal a deeper structural problem.

Which cryptocurrencies are down the most today? Dogecoin has fallen more sharply than Bitcoin, Ethereum, or XRP today, consistent with its tendency to amplify broader market moves due to lower relative liquidity. Ethereum, XRP, and Solana are all down more than 2%, while Bitcoin's decline has been comparatively more modest by comparison. This detail matters most for anyone actively tracking today's market movements.

When will crypto recover from today's dip? There's no fixed timeline. The clearest potential catalysts are a stabilization in the CLARITY Act's Senate outlook, an easing of US-Iran geopolitical tensions and oil prices, or continued Bitcoin ETF inflows extending their current seven-day streak, any of which could shift sentiment relatively quickly given how closely the market has been tracking these stories.

AUTHOR

Brenda is a writer with three years of experience specializing in cryptocurrency, artificial intelligence and emerging technologies. She graduated from the University of Mombasa with a degree in Psychology. She has worked at Cryptopolitan and Blockchain Reporter.

Ethereum’s price faced downward pressure on July 24, but technical signals suggest that further gains are possible if the cryptocurrency can maintain its position above a key support level. Analysts and investors are monitoring ETH’s status above $1,850, which is currently viewed as a critical threshold for the asset’s near-term direction.

Price action and key technical levelsAs of the latest trading session, Ethereum is priced at $1,891.58, representing a 1.13% decline over the previous 24 hours. The coin’s daily trading volume reached $19.26 billion, with a total market capitalization of $228.9 billion. Despite the minor decrease in value, Ethereum remains above a significant technical support region that may dictate its next price movement.

Ali Martinez, a widely followed cryptocurrency analyst, published an update on July 24 reflecting his latest technical assessment of Ethereum. According to Martinez, after retesting its lower price channel, Ethereum experienced a rebound. He believes the $1,850 level serves as essential support and that as long as Ethereum stays above this mark, any upward attempt could set $2,060 as the next resistance to watch.

Ali Martinez identified $1,850 as a crucial support. Sustaining this level could pave the way for a rebound toward $2,060, while any move below would weaken the technical outlook.

At present, Ethereum’s trajectory remains within its established trading channel. Observers said the coming days may prove pivotal in determining whether the current rebound signals a more substantive market recovery.

Derivatives market signals and investor positioningThe derivatives market surrounding Ethereum continues to present a balanced scenario, even following its recent dip.

Open interest, a key measure reflecting open derivative contracts, slipped by 1.50% to $27.34 billion. This change suggests some unwinding of leveraged positions after recent market fluctuations, with less short-term speculation in the market. Meanwhile, trading volume recorded a 7.78% rise to $37.07 billion, reflecting robust market engagement.

MetricCurrent ValueChangePrice$1,891.58-1.13%Market Cap$228.90 billion—Daily Trading Volume$19.26 billion—Open Interest$27.34 billion-1.50%Total Trading Volume$37.07 billion+7.78%This dynamic, where volume increases as open interest drops, indicates that while some investors are closing positions, new participants continue to enter the market. Another notable metric, the OI-weighted funding rate, remained stable at around 0.0005%. This near-zero figure shows a balanced market, with little premium for those taking long or short positions—suggesting buyers and sellers are evenly matched.

Mini dictionary: OI-weighted funding rate, a measure in crypto derivatives that indicates the interest rate paid between long and short position holders, weighted by open interest. It helps signal market bias between buyers and sellers.

Short-term outlook and support levelsThe next several trading sessions could be crucial in establishing Ethereum’s near-term trend. Market participants are watching to see if buyers can sustain momentum above the $1,850 level, while trading activity remains high.

If Ethereum maintains its hold above this support, there is potential for a gradual move toward the resistance at $2,060, as identified by Martinez. Should selling pressure increase and trigger a drop below $1,850, focus may shift to lower support areas.

Currently, Ethereum’s technical framework remains resilient. Analysts note, however, that renewed buyer interest and strong price action would be necessary to signal a convincing recovery in the near term.

Despite current technical strength, sustaining buyer momentum and confirmation through price action will be important for an extended move higher.

Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

Whale 0x446B Dumps 8,010 ETH After Eight Months of SilenceAn Ethereum wallet identified as 0x446B executed a full liquidation of its $ETH holdings on July 24, 2026, offloading 8,010 ETH worth $15.11 million into open market liquidity. On-chain analytics platform Lookonchain confirmed the transaction, noting that the wallet had been completely dormant for eight months before the sudden exit.

The sale resulted in a realized loss of $10.8 million, equivalent to a 37% drawdown from the entity's original cost basis. The figures indicate the wallet accumulated its position at a significantly higher average price, only to exit well below that entry point after an extended period of inactivity.

A Broader Pattern of ETH Whale LossesThe 0x446B exit is not an isolated case. Lookonchain data from early July showed a separate whale selling 2,468 ETH at an average price of $1,572, realising a loss of $4.33 million after originally purchasing the same coins at $3,327. That whale sold 2,468 ETH for $3.88 million, having bought the same position at $3,327 per coin, amounting to $8.21 million.

The pattern reflects a difficult year for longer-term Ethereum holders. An Ethereum whale holding 9,389 ETH for roughly four years is sitting on a $23.8 million unrealized loss, according to Lookonchain. ETH has been trading near $1,780, down roughly 32% year-to-date.

Not all large holders are capitulating. Large withdrawals from centralized exchanges are often interpreted as bullish signals in the cryptocurrency market, and recent weeks have seen a separate cohort of whales moving $ETH off exchanges and into staking rather than selling. Ethereum's staking ratio reached a record 33.9%, representing roughly one-third of the network's circulating supply. The divergence between holders exiting at a loss and others accumulating underscores the uncertainty currently surrounding Ethereum's price outlook.

Sources:
Bitget News: Whale Sold 2,468 ETH, Incurring $4.33 Million Loss (Lookonchain data)
Bitcoin.com: ETH Whale Holds 9,389 ETH at $23.8 Million Unrealized Loss
The Coin Republic: Ethereum Staking Ratio Hits Record 33.9%

5 hours ago

Fu Peng, the newly appointed chief economist of Xinhuo Group, shared his views yesterday, noting that global assets—including the fundamentals of mainstream cryptocurrencies—are tied to liquidity. The current shift from loose to tight liquidity has triggered a "shrinking circle" market trend, with funds flowing into high-certainty core assets. Fu Peng believes the AI industry has reached a critical inflection point, moving from the capital-burning hardware infrastructure phase to value validation. Major players like Google have seen their free cash flow drop to zero, and capital markets no longer endorse the logic of mere capital expenditure expansion. “The AI industrial chain is divided into upstream, midstream, and downstream segments, each with its own independent industry lifecycle, and clear sector rotation shifts and allocation windows. Never treat AI as a 'faith' to hold blindly long-term; turning the AI sector into pure concept speculation will definitely lead to pitfalls.” “The full AI industry cycle spans roughly 20 to 25 years, with the first 10 years already completed. The first decade’s core focus was upstream hardware infrastructure, while the next decade’s will be end-user applications. However, a cycle gap exists currently, and the next 10 to 18 months will be the industry transition window. During this window, do not go all-in; strictly follow industry cycle rules for allocation to avoid volatility risks.” On the other hand, the crypto market will follow liquidity contraction. After the winnowing process, core assets such as Bitcoin and Ethereum will stabilize, while junk coin speculation will become ineffective. Investors need to allocate in stages according to industry cycles and be wary of leverage risks.

Relevant content

Anthropic announces the launch of its Opus 5 AI model.

Anthropic announced the launch of its Opus 5 AI model, which delivers performance nearly matching that of the cutting-edge Fable 5 while costing only half as much.

1 hours ago

Duan Yongping has sold SpaceX put options with a strike price of $92.

Renowned investor Duan Yongping stated yesterday in response to a community user's question that he has started selling put options on SpaceX. This is his typical "potential acquisition" strategy. According to the live trading records of the SpaceX put options Duan shared, his quoted price was around 23.20, with actual execution at 23.26 (1,000 contracts), earning him a premium of approximately $2.32 million. Calculated over a 5-month term, the yield is roughly 25.35%, with an annualized return of about 60%. He noted, "I want to support Elon Musk's dream."

1 hours ago

The United States and the United Kingdom plan to discuss forming an international alliance to protect maritime shipping in the Strait of Hormuz.

According to AXIOS: European diplomats say the U.S. and the U.K. are discussing holding a high-level meeting in London next week, with the meeting focusing on a potential plan to establish an international coalition to protect maritime shipping in the Strait of Hormuz.

1 hours ago

A prominent trader says Bitcoin’s cycle is accelerating, and firmly believes this cycle will still hit a new high before the halving.

Renowned trader Killa (@KillaXBT) stated in a post that Bitcoin’s cycle is accelerating. The previous cycle took just 476 days to rise from its bottom to a new all-time high (ATH), far faster than the two prior cycles. He forecasts this cycle will also hit a new high ahead of the next halving. Killa, a BTC-focused quantitative trader, accurately predicted the peak of the current bull market in May 2025 and boasts over 200,000 followers on X. In mid-April, he shorted Bitcoin at $74,688 before switching to long positions during the broad market sell-off on June 5.

1 hours ago

Qualcomm notifies its customers it can no longer absorb price hikes, and will raise prices by double-digit percentages.

Bloomberg cited a letter reporting that Qualcomm has informed its clients it can no longer absorb price hikes and will implement double-digit percentage price increases. Following the news, BIT (bit.com) market data shows Qualcomm’s decline narrowed, while Nvidia climbed 1.2% to hit a new daily high.

1 hours ago

OpenAI CEO: Hopes the U.S. wins in the open-source AI sector, and is "pleased to see" Jensen Huang's remarks.

OpenAI CEO Sam Altman said he hopes the U.S. will lead in both open-source AI and proprietary AI models, adding that he "welcomes" the statement Nvidia’s CEO made on social media regarding the open letter jointly issued by over 20 U.S. tech companies.

1 hours ago

Hot feeds

Hot Articles

Follow us

Duan Yongping has sold SpaceX put options with a strike price of $92.

Renowned investor Duan Yongping stated yesterday in response to a community user's question that he has started selling put options on SpaceX. This is his typical "potential acquisition" strategy. According to the live trading records of the SpaceX put options Duan shared, his quoted price was around 23.20, with actual execution at 23.26 (1,000 contracts), earning him a premium of approximately $2.32 million. Calculated over a 5-month term, the yield is roughly 25.35%, with an annualized return of about 60%. He noted, "I want to support Elon Musk's dream."

1 hours ago

The United States and the United Kingdom plan to discuss forming an international alliance to protect maritime shipping in the Strait of Hormuz.

According to AXIOS: European diplomats say the U.S. and the U.K. are discussing holding a high-level meeting in London next week, with the meeting focusing on a potential plan to establish an international coalition to protect maritime shipping in the Strait of Hormuz.

1 hours ago

A prominent trader says Bitcoin’s cycle is accelerating, and firmly believes this cycle will still hit a new high before the halving.

Renowned trader Killa (@KillaXBT) stated in a post that Bitcoin’s cycle is accelerating. The previous cycle took just 476 days to rise from its bottom to a new all-time high (ATH), far faster than the two prior cycles. He forecasts this cycle will also hit a new high ahead of the next halving. Killa, a BTC-focused quantitative trader, accurately predicted the peak of the current bull market in May 2025 and boasts over 200,000 followers on X. In mid-April, he shorted Bitcoin at $74,688 before switching to long positions during the broad market sell-off on June 5.

1 hours ago

Qualcomm notifies its customers it can no longer absorb price hikes, and will raise prices by double-digit percentages.

Bloomberg cited a letter reporting that Qualcomm has informed its clients it can no longer absorb price hikes and will implement double-digit percentage price increases. Following the news, BIT (bit.com) market data shows Qualcomm’s decline narrowed, while Nvidia climbed 1.2% to hit a new daily high.

1 hours ago

OpenAI CEO: Hopes the U.S. wins in the open-source AI sector, and is "pleased to see" Jensen Huang's remarks.

OpenAI CEO Sam Altman said he hopes the U.S. will lead in both open-source AI and proprietary AI models, adding that he "welcomes" the statement Nvidia’s CEO made on social media regarding the open letter jointly issued by over 20 U.S. tech companies.

1 hours ago

TLDR: Ethereum price retreated toward $1,880 after sellers blocked its recovery below the psychological $2,000 resistance level. The $1,850 support zone now protects Ethereum’s ascending channel and could determine whether the recent rebound stays intact. Spot Ethereum ETFs recorded $26.3 million in daily inflows, extending their positive flow streak to five trading sessions. Rising open interest and negative funding rates increase liquidation risks as traders build leveraged positions near key price levels. Ethereum price fell toward $1,880 on July 24 after failing to break the psychological $2,000 resistance level. The decline erased part of the recovery that started near $1,560 in late June.

Ether traded near $1,882 at press time, down about 3% over 24 hours. Sellers emerged after ETH reached the $1,935 to $1,950 region earlier this week.

The broader technology-stock sell-off also weakened risk appetite. Major U.S. technology companies lost nearly $797 billion in market value during Thursday’s session.

Bitcoin declined less than 1% and traded near $65,400. Ether’s sharper drop showed that investors continued reducing exposure to higher-risk altcoins.

Ethereum Price Faces Pressure From Leverage and Tech Losses The Ethereum price weakened as Wall Street investors questioned growing artificial-intelligence spending. Alphabet raised its 2026 capital expenditure forecast to as much as $205 billion.

Weaker Tesla earnings also added pressure to technology stocks. The Nasdaq 100 dropped 1.9%, while the S&P 500 declined 1.2%.

Crypto derivatives showed that traders increased exposure before the rejection. Ethereum open interest rose by 600,000 ETH within two days.

Total open interest reached 14.6 million ETH, its highest level since June 7. Rising leverage increased the risk of forced liquidations during sharp price moves.

Funding rates briefly turned negative on Thursday for the first time since June 29. Around $41.55 million in leveraged positions faced liquidation over 24 hours.

Long traders accounted for about $34.4 million of that total. The figures showed that bullish positions absorbed most of the damage during the pullback.

Spot Ethereum ETFs still recorded $26.3 million in net inflows on July 23. The result extended their positive streak to five consecutive trading sessions.

Fidelity’s FETH received $14.9 million, while BlackRock’s ETHA attracted $8.5 million. Grayscale’s mini-Ether fund added another $2.9 million.

The daily total fell from earlier weekly inflows of $38 million, $37.5 million, and $72.7 million. ETF demand therefore failed to offset selling across spot markets.

Ethereum Price Must Hold $1,850 to Protect Recovery Ethereum technical analysis places ETH near the lower boundary of an ascending channel. That structure has guided the recovery since early July.

Ethereum $ETH has rebounded after testing the lower boundary of its channel.

As long as this support at $1,850 continues to hold, I'm watching for a move back toward the upper boundary near $2,060. pic.twitter.com/3H29SDOprG

— Ali Charts (@alicharts) July 24, 2026

Immediate ETH support sits between $1,850 and $1,880. Holding this area could allow buyers to target $1,910 before challenging the $1,950 supply zone.

Crypto analyst Ali Martinez says the channel remains valid while Ethereum holds $1,850. The upper boundary could reach approximately $2,060 during another rebound.

Momentum indicators still favour, sellers in the short term. The four-hour relative strength index dropped to 44.06, below its moving average of 52.62.

The MACD line also fell below its signal line. Its negative histogram showed that bearish momentum continued during the latest session.

The Ethereum price remains above the forward Ichimoku cloud boundary near $1,816 on the daily chart. Chaikin Money Flow stayed positive at 0.07, suggesting capital has not fully left the market.

Liquidation data shows significant leveraged positions near $1,900 and $1,910. Another large liquidity cluster sits between $1,955 and $1,965.

A break above those levels could force short liquidations and reopen the route toward $2,000. Buyers must first reclaim $1,910 with stronger spot volume.

Source: Coinglass Downside liquidity has formed between $1,840 and $1,850, followed by another cluster near $1,820. A four-hour close below $1,850 could expose $1,816.

Further selling could then push ETH toward the $1,750 to $1,730 region. Continued equity weakness or higher bond yields could increase pressure around those lower levels.

The crypto derivatives market just served up another painful reminder that leverage is a double-edged sword. Over the past 24 hours, $271 million in total positions were liquidated across perpetual futures platforms, according to data from Coinglass.

The damage was overwhelmingly one-sided. Long positions accounted for $228.2 million of the carnage, while shorts contributed a comparatively modest $42.8 million.

Bitcoin and Ethereum led the bloodbath Bitcoin longs took the biggest hit, with $120.2 million wiped out. That’s roughly half of all long liquidations in a single asset. Bitcoin shorts, by contrast, only saw $22.1 million liquidated.

Advertisement

Ethereum wasn’t far behind in the pain department. Long positions on ETH accounted for $45.7 million in liquidations, while short liquidations came in at $12.2 million.

The ratio tells the story. For every dollar of short liquidations, roughly $5.33 in longs got blown out. That kind of asymmetry typically signals a swift downward price move that caught leveraged bulls off guard, triggering a cascade of margin calls that fed on itself.

What this means for investors The dominance of long liquidations suggests that bullish sentiment had gotten ahead of itself. The $228.2 million in liquidated longs versus just $42.8 million in shorts tells you the market was leaning hard to one side, and it snapped back.

Coinglass, which aggregates liquidation data across major perpetual futures platforms, monitors exchanges in real time and provides granular breakdowns by asset and position direction, giving traders and analysts a clear view of where leverage is building up and where it’s getting unwound.

One thing is clear: the derivatives market remains a dominant force in crypto price action. When $271 million gets liquidated in a single day, that’s not just a footnote. It’s a market-moving event that feeds directly into spot prices and shapes the trading environment for everyone, leveraged or not.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

The price of Ethereum [ETH] was down 1.77% in the past 24 hours. Daily trading volume dipped by just over 6%, and Open Interest has slid by 3.2%. CoinGlass data showed that long liquidations might help explain the recent price drop.

The bullish derivatives traders faced around $67 million in liquidations, measured from July 22. These liquidations forced sell orders to close the position in perpetual markets, increasing the sell pressure on ETH.

CryptoQuant data showed that the funding rate was positive but declining. Since the first week of July, the 7-day moving average of the funding rate has dipped from +0.0088% to +0.0054%, a mildly positive reading.

Source: CryptoQuant The taker buy/sell ratio measures the proportion of aggressive [market] buying versus selling volume. This metric fell deep into negative territory recently. However, its 7-day moving average has not slipped below zero, as it did in May.

The Ethereum price action is likely to turn bearish now AMBCrypto reported on whale accumulation and improved ETF demand recently. The network’s validator queue has also dropped to zero with no waiting time, signaling conviction from long-term stakers.

Source: ETH/USDT on TradingView The price charts told a different story. On the 1-day timeframe, the swing structure remains firmly bearish. A breakdown below the February low at $1,742 in early June confirmed this.

At the time of writing, Ethereum was experiencing a price bounce, but has not managed to reach key Fibonacci retracement levels.

Traders’ call to action- Sell Source: ETH/USDT on TradingView Another set of Fibonacci retracement levels was plotted based on the late May-early June selloff. Back then, the Ethereum price raced lower from $2,043 to $1,510. Earlier this week, the 78.6% retracement level had been tested.

ETH bulls have faced a setback from the resistance level at $1,929. The 4-hour and 1-day timeframes were in agreement on a bearish bias. As things stand, a price drop toward $1,510 appeared likely.

A rally beyond $2,043 would invalidate this bearish case.

Final Summary The Ethereum whale accumulation and cleared validator queues signaled long-term conviction, but the price charts remained bearish. The derivatives market saw aggressive sell pressure in the past 48 hours, and the funding rate has been sliding lower, showing a cool-off in demand.

Cover image via depositphotos.com Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Even though the meme cryptocurrency is still trading close to multi-month lows, Dogecoin has seen a significant increase in trading activity, with 24-hour spot volume rising by more than 123%. The increase in participation indicates that traders are becoming more active in the current support zone, even though price action is still weak. 

Dogecoin's volumes riseThe most recent market data shows that DOGE's spot trading volume has increased to about $219 million, and its futures volume has reached about $1.5 billion. The fact that open interest is more than $1.1 billion shows that leveraged traders are still heavily exposed even though the asset is having difficulty making a significant comeback. But from a technical standpoint, the chart is still very negative. 

DOGE/USDT Chart by TradingViewAfter yet another rejection below the 26-day exponential moving average, which is now close to $0.074, Dogecoin is trading at about $0.069. Additionally, the price is still significantly below the 50-day EMA at $0.078 and the 100-day EMA at $0.087, indicating that sellers continue to control the medium- and longer-term trends. 

HOT Stories

The 200-day moving average, which is currently above $0.10, is still sloping downward, indicating how much more work bulls have ahead of them before a structural reversal is feasible. Momentum indicators are just as cautious. With an RSI of roughly 34–35, DOGE is in the vicinity of oversold territory.

You Might Also Like

Even though that raises the likelihood of a technical bounce, oversold conditions by themselves seldom indicate a long-term bottom during established downtrends. It is interesting to note that derivatives positioning paints a more positive picture. 

Who's exposed to DOGE?Top traders on Binance and OKX have substantially more long than short exposure, and long-to-short ratios on major exchanges continue to be strongly skewed toward bullish wagers. However, this optimism has not yet resulted in persistent spot market buying pressure. 

Thus, the rise in trading volume warrants consideration. Increasing volume during a protracted decline frequently indicates one of two things: either accumulation as larger players covertly take supply from weaker hands, or capitulation as remaining holders give up their positions. 

Price confirmation is necessary to differentiate between those results. As of right now, Dogecoin is still printing lower highs and lower lows, indicating that the trend has not altered. Bulls' first task is still to recover the 26-day EMA at $0.074. A stronger breakout would aim for the $0.087 resistance zone, while a move above that level might set off a recovery toward the 50-day EMA near $0.078. 

"The next big move could shock everyone," one analyst predicted.

The biggest meme coin by market capitalization is down 12% over the past month, while its most recent plunge below a critical level suggests sellers may now be in full control.

On the other hand, Ali Martinez pointed to the formation of a rare setup that could be a precursor to a major bull run.

Will Bears Keep the Wheel? DOGE has tumbled by roughly 5% on a 24-hour scale and is currently worth around $0.069 (according to CoinGecko). The X account BSCN noted that in its weekly anomaly report, Santiment flagged the meme coin as “hype without news,” warning that a price drop below $0.071 would hand control to the sellers.

“Santiment’s core read was that DOGE trades as amplified Bitcoin beta, falling harder in selloffs, and this session proved it on cue,” it added.

According to the analytics platform, a quick reclaim of the key $0.071 zone would repair the setup, but staying beneath it would indicate that bears continue to dominate.

Other market observers who also touched upon DOGE include Kamran Asghar and Scient. The former claimed that the token is approaching “a make or break” level, predicting that “the next big move could shock everyone.” The latter was firmly on the bearish side, expecting a further drop in the coming days.

The Bullish Signals Contrary to its poor performance as of late, the renowned analyst Ali Martinez outlined that DOGE’s weekly TD Sequential indicator has flashed numerous consecutive buy signals. He labeled the development “a rare setup that could be warning a major bull rally is approaching.”

X user Cryptollica chipped in, too, noting the “dead attention” surrounding Dogecoin recently. At the same time, they believe this is the best moment to jump on the bandwagon, saying:

You may also like: Mining Profits Dry Up Across Bitcoin, DOGE, LTC, and BCH Could Dogecoin (DOGE) Be Setting Up for Its Next Big Move? Analysts Think So ‘Dead Meme’ or Major Opportunity? DOGE Is Flashing The Same Signal That Preceded Its Biggest Rallies “Invest when no one else cares. That way, you will make money.”

The institutional interest is also worth mentioning. Earlier this week, spot DOGE ETFs witnessed their first green day since mid-June. However, the capital flowing into these products remains negligible, and appetite from big players like pension funds and hedge funds should seriously increase to positively impact the price.

Spot DOGE ETFs, Source: SoSoValue Tags: